Google Sister Company, Verily Life Sciences Introduces Employee Health Screening Tool That Could Drive COVID-19 Test Volumes for Clinical Laboratories

Google Verily public health partnership for COVID-19 employee screening
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on email
Email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

Employee screening tools being developed by technology companies create unique opportunity for clinical laboratories to pursue strategic partnerships.

Verily Life Sciences is a research company founded by Alphabet, Google’s parent company, in 2015. Verily has played an important role in the COVID-19 response since the early days of the outbreak in the United States. In early March 2020, Verily gained national attention with its COVID-19 screening tool and, according to the company, has helped over 200,000 people to identify a need for COVID-19 testing.

Recently, Verily shifted focus to providing screening and testing to employers who are seeking to ensure that their customers and employees are safe. This service, called “Healthy at Work”, was announced June 18. According to Verily’s website, “Healthy at Work integrates COVID-19 testing, symptom screening, population analytics and ongoing safety controls to help organizations operationalize their plans to return to work and campus.”

“Employers are really focusing on how to ensure that they are not the source of another outbreak,” Dr. Vivian Lee, President of Health Platforms at Verily, told the New York Times in a recent interview. “And that they do not wind up in a situation where they’re putting the safety of their employees at risk when they need to be back in an office or a workplace setting.”

Adding COVID-19 to Selection of Health Condition Monitoring

While details about this new tool are still emerging as it continues in development, Verily indicated that this tool will be coupled with Verily’s Baseline COVID-19 Testing Program—the program launched in early March as the pandemic was starting. Verily’s Baseline COVID-19 Testing Program connects those who use Verily’s COVID-19 screening tool, and are found to need diagnostic COVID-19 testing, with a growing network of partner laboratories. 

Moreover, as part of Project Baseline, the attraction of COVID-19 has the potential to go deeper as Project Baseline has been part of a study to comprehensively map human health. As such, COVID-19 represents a new dataset to possibly study in concert with other health conditions and medical laboratory test results.

Tech Companies Vie for Employee Health Program COVID-19 Services

Verily is not the only tech company to focus on COVID-19 employee screening. UnitedHealth Group and Microsoft have recently partnered to create an employee screening app called ProtectWell. According to a joint press release: “ProtectWell helps employees determine they are safe to go to work, co-workers know their colleagues have been screened, and employers feel confident that their workplace is ready to do business.” Fitbit has also recently introduced a program with a daily symptom-checking app for employees and an employer dashboard that allows workforce health monitoring.

Will Innovative COVID-19 Partnerships Drive Higher Clinical Laboratory Test Volumes?

Clinical laboratories and pathology groups should be aware of recent innovations in the tech industry that will affect COVID-19 test volumes. As large, influential technology companies focus more on offering employee screening tools, the increased awareness of the need for related testing and demand by employers will likely grow.

Developing, tech-based employee screening tools may also enable clinical laboratories and pathology groups to explore strategic partnerships. 

While the structure of Verily’s employee COVID-19 testing is still developing, it appears likely that it will be integrated with their existing COVID-19 network that includes public health and private clinical laboratories. Verily is actively soliciting partnerships for this testing program and the increased need for testing that will likely occur as employee screening becomes more widely utilized. Ultimately, such combined efforts will likely create a unique opportunity for clinical laboratories.

Caleb Williams

—By Caleb Williams, Editor, COVID-19 STAT           

Related Resources:

New York Times: Big Tech Zeros In on the Virus-Testing Market

Verily Healthy at Work Employee Screening

Verily COVID-19 Testing Partnerships

Verily Launches Landmark Study with Duke and Stanford as First Initiative of Project Baseline

Microsoft and UnitedHealth Group Employee Screening Tool Press Release

New Study from Fitbit Seeks to Advance COVID-19 and Flu Research with Early Detection

COVID-19 TESTING DATA

Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at rmichel@darkreport.com.

Sincerely,

Robert L. Michel
President, Founder
The Dark Intelligence Group